Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dorn

Showing results (91-100 of 393) with videos related to

Pageof 40
Sort By:
Violence and Victims|November 11, 1998
Effects of time and an educational presentation on student attitudes toward wife-beatingM F O'Neal, P W Dorn
Rational Drug Therapy|July 1, 1985
Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular diseaseG W Dorn, P V Halushka
Journal of Cardiac Failure|January 30, 2003
Signaling pathways involved in left ventricular remodeling: summationGerald W Dorn, Douglas L Mann
Circulation. Cardiovascular Genetics|December 22, 2011
Clinical considerations of heritable factors in common heart failureThomas P Cappola, Gerald W Dorn
The American Journal of Physiology|April 1, 1992
Growth factors downregulate vascular smooth muscle thromboxane receptors independent of cell growthG W Dorn, M W Becker
Circulation Research|April 26, 2014
Menage a Trois: intimate relationship among a microRNA, long noncoding RNA, and mRNAGerald W Dorn, Scot J Matkovich
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cellsG W Dorn, M G Davis
Annual Review of Physiology|February 5, 2002
Intracellular transport mechanisms of signal transducersGerald W Dorn, Daria Mochly-Rosen
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Thromboxane A2 stimulated signal transduction in vascular smooth muscleG W Dorn, M W Becker
Oncogene|July 31, 2009
Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3LG W Dorn, L A Kirshenbaum
Pageof 40

Showing results (91-100 of 393) with videos related to

Sort By:
Pageof 40
Violence and Victims|November 11, 1998
Effects of time and an educational presentation on student attitudes toward wife-beatingM F O'Neal, P W Dorn
Rational Drug Therapy|July 1, 1985
Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular diseaseG W Dorn, P V Halushka
Journal of Cardiac Failure|January 30, 2003
Signaling pathways involved in left ventricular remodeling: summationGerald W Dorn, Douglas L Mann
Circulation. Cardiovascular Genetics|December 22, 2011
Clinical considerations of heritable factors in common heart failureThomas P Cappola, Gerald W Dorn
The American Journal of Physiology|April 1, 1992
Growth factors downregulate vascular smooth muscle thromboxane receptors independent of cell growthG W Dorn, M W Becker
Circulation Research|April 26, 2014
Menage a Trois: intimate relationship among a microRNA, long noncoding RNA, and mRNAGerald W Dorn, Scot J Matkovich
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cellsG W Dorn, M G Davis
Annual Review of Physiology|February 5, 2002
Intracellular transport mechanisms of signal transducersGerald W Dorn, Daria Mochly-Rosen
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Thromboxane A2 stimulated signal transduction in vascular smooth muscleG W Dorn, M W Becker
Oncogene|July 31, 2009
Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3LG W Dorn, L A Kirshenbaum
Pageof 40